학술논문

Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis
Document Type
Journal
Source
MOLECULAR CANCER THERAPEUTICS; MAR 2012, 11 3, p680-p689, 10p.
Subject
Language
English
ISSN
15357163